Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000320935 | SCV000336925 | benign | not specified | 2015-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000320935 | SCV000715760 | likely benign | not specified | 2017-02-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002059152 | SCV002325343 | benign | Glycogen storage disease IXa1 | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021159 | SCV005002746 | benign | Inborn genetic diseases | 2022-05-09 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |